Despite the intense scientific efforts made, there are still many tumors that are difficult to treat and the percentage of patient survival in the long-term is still too low. Thus, new approaches to the treatment of cancer are needed. Cancer is a highly heterogeneous and complex disease, whose development requires a reorganization of cell metabolism. Most tumor cells downregulate mitochondrial oxidative phosphorylation and increase the rate of glucose consumption and lactate release, independently of oxygen availability (Warburg effect). This metabolic rewiring is largely believed to favour tumor growth and survival, although the underlying molecular mechanisms are not completely understood. Importantly, the correlation between the aerobic glycolysis and cancer is widely regarded as a useful biochemical basis for the development of novel anticancer strategies. Among the enzymes involved in glycolysis, lactate dehydrogenase (LDH) is emerging as a very attractive target for possible pharmacological approaches in cancer therapy. This review addresses the state of the art and the perspectives concerning LDH both as a useful diagnostic marker and a relevant molecular target in cancer therapy and management.

Lactic dehydrogenase and cancer: an overview / Gallo, Monica; Luigi, Sapio; Annamaria, Spina; Naviglio, Daniele; Calogero, Armando; Silvio, Naviglio. - In: FRONTIERS IN BIOSCIENCE. - ISSN 1093-9946. - 20:(2015), pp. 1234-1249. [10.2741/4368.]

Lactic dehydrogenase and cancer: an overview

GALLO, MONICA;NAVIGLIO, DANIELE;CALOGERO, ARMANDO;
2015

Abstract

Despite the intense scientific efforts made, there are still many tumors that are difficult to treat and the percentage of patient survival in the long-term is still too low. Thus, new approaches to the treatment of cancer are needed. Cancer is a highly heterogeneous and complex disease, whose development requires a reorganization of cell metabolism. Most tumor cells downregulate mitochondrial oxidative phosphorylation and increase the rate of glucose consumption and lactate release, independently of oxygen availability (Warburg effect). This metabolic rewiring is largely believed to favour tumor growth and survival, although the underlying molecular mechanisms are not completely understood. Importantly, the correlation between the aerobic glycolysis and cancer is widely regarded as a useful biochemical basis for the development of novel anticancer strategies. Among the enzymes involved in glycolysis, lactate dehydrogenase (LDH) is emerging as a very attractive target for possible pharmacological approaches in cancer therapy. This review addresses the state of the art and the perspectives concerning LDH both as a useful diagnostic marker and a relevant molecular target in cancer therapy and management.
2015
Lactic dehydrogenase and cancer: an overview / Gallo, Monica; Luigi, Sapio; Annamaria, Spina; Naviglio, Daniele; Calogero, Armando; Silvio, Naviglio. - In: FRONTIERS IN BIOSCIENCE. - ISSN 1093-9946. - 20:(2015), pp. 1234-1249. [10.2741/4368.]
File in questo prodotto:
File Dimensione Formato  
4368.pdf

accesso aperto

Licenza: Dominio pubblico
Dimensione 288.7 kB
Formato Adobe PDF
288.7 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/610812
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 86
  • ???jsp.display-item.citation.isi??? 83
social impact